Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 465

    1.

    Inhibition of antithrombin by hyaluronic acid may be involved in the pathogenesis of rheumatoid arthritis.

    Chang X, Yamada R, Yamamoto K.

    Arthritis Res Ther. 2005;7(2):R268-73. Epub 2005 Jan 11.

    PMID:
    15743473
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    The anticoagulant effect of heparan sulfate and dermatan sulfate.

    Teien AN, Abildgaard U, Höök M.

    Thromb Res. 1976 Jun;8(6):859-67. No abstract available.

    PMID:
    134464
    [PubMed - indexed for MEDLINE]
    3.

    Mechanisms for the anticoagulant effect of heparin and related polysaccharides.

    Ofosu FA.

    Nouv Rev Fr Hematol. 1988;30(3):155-60. Review.

    PMID:
    2971155
    [PubMed - indexed for MEDLINE]
    4.

    Heparan sulfate and dermatan sulfate inhibit the generation of thrombin activity in plasma by complementary pathways.

    Ofosu FA, Modi GJ, Smith LM, Cerskus AL, Hirsh J, Blajchman MA.

    Blood. 1984 Sep;64(3):742-7.

    PMID:
    6235872
    [PubMed - indexed for MEDLINE]
    Free Article
    5.

    Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.

    Ofosu FA, Buchanan MR, Anvari N, Smith LM, Blajchman MA.

    Ann N Y Acad Sci. 1989;556:123-31.

    PMID:
    2525356
    [PubMed - indexed for MEDLINE]
    6.

    Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides.

    Ofosu FA, Modi GJ, Hirsh J, Buchanan MR, Blajchman MA.

    Ann N Y Acad Sci. 1986;485:41-55.

    PMID:
    2436525
    [PubMed - indexed for MEDLINE]
    7.

    Effect of glycosaminoglycans on the growth of cultured tumor cells.

    Nagasawa S.

    J Osaka Dent Univ. 1993 Oct;27(2):121-33.

    PMID:
    8182504
    [PubMed - indexed for MEDLINE]
    8.

    Synovial fluid chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in arthritic and normal knees.

    Belcher C, Yaqub R, Fawthrop F, Bayliss M, Doherty M.

    Ann Rheum Dis. 1997 May;56(5):299-307.

    PMID:
    9175930
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    Coagulation protein function: enhancement of the anticoagulant effect of acetaldehyde by sulfated glycosaminoglycans.

    Brecher AS, Adamu MT.

    Dig Dis Sci. 2001 Sep;46(9):2033-42.

    PMID:
    11575460
    [PubMed - indexed for MEDLINE]
    10.

    Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.

    Scully MF, Ellis V, Seno N, Kakkar VV.

    Biochem J. 1988 Sep 1;254(2):547-51.

    PMID:
    2902851
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    11.

    Inactivation of antithrombin III in synovial fluid from patients with rheumatoid arthritis.

    Jones HW, Bailey R, Zhang Z, Dunne KA, Blake DR, Cox NL, Morris CJ, Winyard PG.

    Ann Rheum Dis. 1998 Mar;57(3):162-5.

    PMID:
    9640132
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    12.

    Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and glycosaminoglycans in synovial fluid from patients with rheumatoid arthritis.

    Ishiguro N, Ito T, Miyazaki K, Iwata H.

    J Rheumatol. 1999 Jan;26(1):34-40.

    PMID:
    9918237
    [PubMed - indexed for MEDLINE]
    13.

    Inhibition of the early stages of the thrombin generation reaction by various glycosaminoglycans.

    Visser A, Meuleman DG.

    Thromb Res. 1990 Jun 1;58(5):469-79.

    PMID:
    2164263
    [PubMed - indexed for MEDLINE]
    14.

    The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis.

    Chang X, Yamada R, Sawada T, Suzuki A, Kochi Y, Yamamoto K.

    Rheumatology (Oxford). 2005 Mar;44(3):293-8. Epub 2004 Nov 23. Erratum in: Rheumatology (Oxford). 2005 Apr;44(4):569.

    PMID:
    15561738
    [PubMed - indexed for MEDLINE]
    Free Article
    15.

    Glycosaminoglycans enhance human leukemic cell growth in vitro.

    Maurer AM, Han ZC, Dhermy D, Brière J.

    Leuk Res. 1994 Nov;18(11):837-42.

    PMID:
    7967710
    [PubMed - indexed for MEDLINE]
    16.

    Activation of heparin cofactor II by dermatan sulfate.

    Tollefsen DM, Pestka CA, Monafo WJ.

    J Biol Chem. 1983 Jun 10;258(11):6713-6.

    PMID:
    6687888
    [PubMed - indexed for MEDLINE]
    17.

    Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.

    Volpi N, Petrini M, Conte A, Valentini P, Venturelli T, Bolognani L, Ronca G.

    Exp Cell Res. 1994 Nov;215(1):119-30.

    PMID:
    7957660
    [PubMed - indexed for MEDLINE]
    18.

    Effect of glycosaminoglycans on thrombin-induced clotting of normal and antithrombin III-deficient plasmas.

    Kindness G, Long WF, Williamson FB, Edward M, Winter JH, Bennett NB.

    Thromb Res. 1980 Feb 1-15;17(3-4):539-44. No abstract available.

    PMID:
    6768163
    [PubMed - indexed for MEDLINE]
    19.

    Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.

    Okwusidi JI, Anvari N, Kulczycky M, Blajchman MA, Buchanan MR, Ofosu FA.

    J Lab Clin Med. 1991 May;117(5):359-64.

    PMID:
    2019790
    [PubMed - indexed for MEDLINE]
    20.

    Role of glycosaminoglycans in the regulation of T cell proliferation induced by thymic stroma-derived T cell growth factor.

    Kimura K, Matsubara H, Sogoh S, Kita Y, Sakata T, Nishitani Y, Watanabe S, Hamaoka T, Fujiwara H.

    J Immunol. 1991 Apr 15;146(8):2618-24.

    PMID:
    1901881
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk